Skip to content

Evaluation of a monitoring method using blockchain technology using medical data of spondylosis patients

Evaluation of a monitoring method using blockchain technology using medical data of spondylosis patients - Evaluation of a monitoring method using blockchain technology using medical data of spondylosis patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000045067
Enrollment
20
Registered
2021-08-10
Start date
2021-08-20
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

spondylosis

Interventions

None listed

Sponsors

Tokyo Medical and Dental University
Lead Sponsor
SUSMED, Inc
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Patients diagnosed with spondylosis at the time of screening and clinically eligible for treatment with NSAIDs (2) Patients who have pain in the upper or lower extremities caused by spondylosis and have been in pain for longer than 3 months prior to screening (3) Patients aged 20 years or older at the time of consent (4) Patients who understand the procedures of this study, can answer questions in Japanese appropriately without assistance, and can give written consent to participate in this study

Exclusion criteria

Exclusion criteria: (1) Patients who have severe pain other than spondylosis at the time of screening and are considered difficult to evaluate (2) Patients with painful bone fractures (3) Patients with serious hepatic, renal, or cardiac diseases that would make it difficult to participate in this study (4) Patients who have Brief Scale for Psychiatric Problems in Orthopaedic Patients (BS-POP) score with 11 points or more for physicians, or with 10 points or more for physicians and 15 points or more for patients, at screening (5) Patients who are judged unsuitable for participation in this study by the principal investigator or sub-investigator at the time of screening or study enrollment

Design outcomes

Primary

MeasureTime frame
(1) Difference in the time required for monitoring activities (average of the total time required for CRF checks) (2) Difference in the number of queries raised by monitoring activities (average of the total number of queries pointed out in each CRF check)

Countries

Japan

Contacts

Public ContactHiroya Kuwahara

Tokyo Medical and Dental University Medical Innovation Promotion Center/Department of Neurology

h-kuwahara.nuro@tmd.ac.jp03-5803-5234

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026